The
mu-opioid receptor is an
autoreceptor on hypothalamic
beta-endorphin neurons that when activated inhibits cell firing via increasing an inwardly rectifying
potassium conductance. The membrane hyperpolarization to
DAMGO ([D-Ala2, N-Me-Phe4, Gly-ol5]-
enkephalin) in
beta-endorphin and other arcuate (
ARC) neurons was investigated in hypothalamic slices from control and
morphine-treated, ovariectomized guinea pigs. Chronic
morphine treatment caused both a decreased potency (EC50 220 +/- 10 nM vs. 64 +/- 3 nM in controls) and a decreased efficacy (Vmax: -7.1 +/- 1.1 mV vs. -10.7 +/- 0.6 mV in controls) of
DAMGO in a population of
ARC neurons including
beta-endorphin neurons. In another population of
ARC neurons from
morphine-treated animals,
DAMGO was less potent (EC50: 110 +/- 4 nm) than in controls (EC50: 64 +/- 3nM), but there was not a significant change in the efficacy of
DAMGO. Twenty percent of
ARC neurons did not exhibit any signs of tolerance. The density of
mu-opioid receptors labeled with the antagonist radioligand [3H]
diprenorphine was found to be significantly decreased in the
ARC and surrounding mediobasal hypothalamus after
morphine treatment (Bmax: 217 +/- 9 vs. 276 +/- 16 fmol/mg
protein in controls), which is consistent with the altered response in
beta-endorphin neurons. In summary, chronic
morphine treatment decreases
mu-opioid receptor density and the functional coupling of
mu-opioid receptors to K+ channels in
ARC neurons. This expression of
morphine tolerance by
beta-endorphin (
ARC) neurons may serve as a homeostatic mechanism to maintain
opioid control of a variety of systems ranging from reproduction to motivation and reward.